Medium materiality6/10
Atea Pharmaceuticals price target raised to $7 from $6 at Morgan Stanley
Why it may matterVerify against the original reporting
Upside potential supported by higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises AVIR target to $7; current price about $5.06; modest price move.
- Target $7 vs price $5.06; upside potential.
Key facts
- 01
Target: $7
- 02
Posted price: $5.06
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.